Products Tetanus Immune Globulin (Human) + Diphtheria-Tetanus Toxoids Adsorbed
Tetanus Immune Globulin (Human) + Diphtheria-Tetanus Toxoids Adsorbed Approved Terminated 🔥 Hot Mar 1, 2007 → Sep 1, 2007
About Tetanus Immune Globulin (Human) + Diphtheria-Tetanus Toxoids Adsorbed Tetanus Immune Globulin (Human) + Diphtheria-Tetanus Toxoids Adsorbed is a approved stage product being developed by Grifols for Tetanus. The current trial status is terminated. This product is registered under clinical trial identifier NCT00437671. Target conditions include Tetanus.
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT00437671 Approved Terminated Mar 1, 2007 Sep 1, 2007 Tetanus
Product Company Stage Hype Score Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®) + Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (BOOSTRIX®) Sanofi Approved Tetanus-diphtheria-acellular pertussis (Tdap) vaccine Sanofi Approved Diphtheria and Tetanus Toxoids and Acellular Pertussis + Measles, Mumps, Rubella + Varicella Virus + Diphtheria and Tetanus Toxoids and Acellular Pertussis + Poliovirus + MMR + Varicella Virus + Diphtheria and Tetanus Toxoids and Acellular Pertussis + Measles, Mumps, Rubella + Varicella Virus + Diphtheria and Tetanus Toxoids and Acellular Pertussis + Poliovirus + MMR + Varicella Virus Sanofi Phase 3 Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Adsorbed + Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Adsorbed Sanofi Approved DTaP-IPV/Hib Combined vaccine + DTaP-IPV vaccine and Hib vaccine + DTaP-IPV/Hib Combined vaccine Sanofi Phase 3 Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed + Diphtheria and Tetanus toxoids adsorbed Sanofi Phase 3 Tetanus Toxoid, Diphtheria Toxoid and Pertussis Vaccine + Tetanus and Diphtheria Toxoids Adsorbed For Adult Use Sanofi Approved Tdap (Tetanus Toxoid Reduced Diphtheria Toxoid/Acellular Pertussis) + DTaP (Diphtheria & Tetanus Toxoids & Acellular Pertussis Adsorbed) Sanofi Phase 3 Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed Formulation 1 + Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 2 + Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 3 + Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 4 + Licensed Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed + Licensed Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Sanofi Phase 1/2 Investigational Tdap vaccine Formulation B + Investigational Tdap vaccine Formulation C + Investigational Tdap vaccine Formulation A + Investigational Tdap vaccine Formulation D + Licensed Tdap vaccine Sanofi Phase 1
Other Products from Grifols